RhumbLine Advisers’s Medicines Co MDCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q1
Sell
-260,584
Closed -$22.1M 2967
2019
Q4
$22.1M Buy
260,584
+22,098
+9% +$1.88M 0.04% 445
2019
Q3
$11.9M Buy
238,486
+16,903
+8% +$845K 0.02% 689
2019
Q2
$8.08M Buy
221,583
+25,855
+13% +$943K 0.02% 910
2019
Q1
$5.47M Buy
195,728
+107
+0.1% +$2.99K 0.01% 1124
2018
Q4
$3.74M Buy
195,621
+35,238
+22% +$674K 0.01% 1272
2018
Q3
$4.8M Sell
160,383
-2,758
-2% -$82.5K 0.01% 1135
2018
Q2
$5.99M Buy
163,141
+4,642
+3% +$170K 0.01% 982
2018
Q1
$5.22M Buy
158,499
+2,139
+1% +$70.5K 0.01% 1012
2017
Q4
$4.28M Buy
156,360
+14,090
+10% +$385K 0.01% 1171
2017
Q3
$5.27M Sell
142,270
-3,335
-2% -$124K 0.01% 997
2017
Q2
$5.53M Buy
145,605
+58
+0% +$2.2K 0.01% 949
2017
Q1
$7.12M Buy
145,547
+40,945
+39% +$2M 0.02% 811
2016
Q4
$3.55M Buy
104,602
+3,906
+4% +$133K 0.01% 1123
2016
Q3
$3.8M Buy
100,696
+5,323
+6% +$201K 0.01% 1041
2016
Q2
$3.21M Sell
95,373
-27,537
-22% -$926K 0.01% 1061
2016
Q1
$3.91M Buy
122,910
+10,790
+10% +$343K 0.01% 975
2015
Q4
$4.19M Buy
112,120
+5,080
+5% +$190K 0.01% 912
2015
Q3
$4.06M Buy
107,040
+4,060
+4% +$154K 0.01% 915
2015
Q2
$2.95M Buy
102,980
+18,065
+21% +$517K 0.01% 1156
2015
Q1
$2.38M Buy
84,915
+8,315
+11% +$233K 0.01% 1287
2014
Q4
$2.12M Sell
76,600
-2,415
-3% -$66.8K 0.01% 1321
2014
Q3
$1.76M Sell
79,015
-2,510
-3% -$56K 0.01% 1406
2014
Q2
$2.37M Buy
81,525
+691
+0.9% +$20.1K 0.01% 1258
2014
Q1
$2.3M Sell
80,834
-2,970
-4% -$84.4K 0.01% 1259
2013
Q4
$3.24M Buy
83,804
+4,330
+5% +$167K 0.01% 1063
2013
Q3
$2.66M Buy
79,474
+2,449
+3% +$82.1K 0.01% 1165
2013
Q2
$2.37M Buy
+77,025
New +$2.37M 0.01% 1194